- βCGM cut dangerous low blood sugar time in half for kidney disease patients
- βOver 51% of patients had hidden low blood sugars revealed, allowing safer insulin adjustments
- βNearly two-thirds of patients saw improved long-term blood sugar (HbA1c) after starting CGM
| Journal | Diabetic medicine : a journal of the British Diabetic Association |
| Year | 2026 |
| PMID | 41254466 |
What This Study Found
Researchers looked at how continuous glucose monitors (CGMs) helped 177 adults who had both type 2 diabetes and chronic kidney disease (CKD). These patients are at especially high risk of dangerous low blood sugar episodes.
Why This Matters
People with kidney disease process insulin differently, making low blood sugar (hypoglycaemia) more likely and harder to predict. Traditional finger-prick testing can miss these episodes, but a CGM tracks glucose levels continuously throughout the day and night.
Key Results
- Time spent with dangerously low blood sugar was cut in half after starting CGM use.
- In 51% of patients, CGM revealed hidden low blood sugars that led doctors to safely reduce their insulin doses.
- 64% of patients saw their HbA1c (average blood sugar over 3 months) improve after using CGM.
What This Means for You
If you have type 2 diabetes and kidney disease, a CGM could reveal blood sugar lows you didn't know you were having. This information can help your doctor adjust your insulin to keep you safer. Talk to your diabetes care team about whether a CGM is right for your situation.
